PMC38 COMPARISON OF TWO METHODS TO DETERMINE COSTS FOR AML PATIENTS IN REMISSION: MODEL VALIDATION FROM A UK PERSPECTIVEdoi:10.1016/s1098-3015(10)74940-8C PurdyRS MagarA HaywardTR EinarsonElsevier
PMC38 COMPARISON OF TWO METHODS TO DETERMINE COSTS FOR AML PATIENTS IN REMISSION: MODEL VALIDATION FROM A UK PERSPECTIVEdoi:10.1016/S1098-3015(10)74940-8CPurdyandRSMagarandAHaywardandTRSDOSValue in Health